Proposed Data Collections Submitted for Public Comment and Recommendations, 36065-36066 [2014-14788]
Download as PDF
<![CDATA[
36065
Federal Register / Vol. 79, No. 122 / Wednesday, June 25, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
Focus Group Discussion Guide .......
Total ...........................................
400
1
2
800
...........................................................
........................
........................
........................
1,680
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–14834 Filed 6–24–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–14–0870]
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
VerDate Mar<15>2010
18:01 Jun 24, 2014
Jkt 232001
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Monitoring and Reporting System for
Chronic Disease Prevention and Control
Programs (OMB No. 0920–0870, exp.
11/30/2014)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Tobacco use is the single most
preventable cause of death and disease
in the United States. Tobacco use causes
heart disease and strokes, lung cancer
and many other types of cancer, chronic
obstructive pulmonary disease, lung
disorders, pregnancy problems, sudden
infant death syndrome, gum disease,
and vision problems. Approximately
480,000 Americans die from tobaccorelated illnesses annually, a higher
number of deaths than the combined
total deaths from HIV/AIDS, alcohol
use, cocaine use, heroin use, homicides,
suicides, motor vehicle crashes, and
fires. For every person who dies from
tobacco use, 20 more people suffer with
at least one serious tobacco-related
illness. There are also severe economic
consequences of tobacco use as the U.S.
spends approximately $280 billion
annually in direct medical expenses and
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
lost productivity attributable to the
effects of tobacco use.
The National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP) provides
funding to health departments in States,
territories, and the District of Columbia
to implement and evaluate chronic
disease prevention and control
programs, including tobacco control
programs. Currently, CDC has
cooperative agreements to support
tobacco control programs in all 50 states
and the District of Columbia under FOA
DP14–1415, an extension of FOA DP09–
901. These cooperative agreements
technically ended on March 28, 2014,
however a one-year cost extension
(DP14–1415) was granted. Due to the
cost extension, final reports on awardee
activities are due to CDC approximately
90 days after the end of the funding
period (June 26, 2015).
In order to maintain continuity in
progress reporting through the end of
the cost extension, CDC requests OMB
approval to continue the collection of
information from tobacco control
program awardees for one year.
Awardees will continue to submit semiannual progress reports through a Webbased management information system
(MIS).
CDC will continue to collect
information about each awardee’s
tobacco control objectives, planning,
activities, resources, partnerships,
strategies, and progress toward meeting
objectives. Awardees will use the
information reported through the
electronic MIS to manage and
coordinate their activities and to
improve their efforts. CDC will use the
information reported through the MIS to
document and monitor each awardee’s
progress and to make adjustments, as
needed, in the type and level of
technical assistance provided to them.
The information collection allows CDC
to oversee the use of federal funds, and
identify and disseminate information
about successful tobacco control
strategies implemented by awardees.
CDC also uses the information to
respond to Congressional and
stakeholder inquiries about awardee
E:\FR\FM\25JNN1.SGM
25JNN1
36066
Federal Register / Vol. 79, No. 122 / Wednesday, June 25, 2014 / Notices
activities, program implementation, and
program impact.
Progress reporting through the MIS is
required for CDC funded awardees.
There are no costs to respondents other
than their time. There are no changes to
the content of the information
collection, the frequency of information
collection, or the estimated burden per
response. The only change is a decrease
in the number of tobacco control
program respondents from 53 to 51.
Puerto Rico and the Virgin Islands were
originally funded under DP09–901 but
discontinued their participation under
the DP14–1415 cost extension. As a
result, the total estimated annualized
burden hours will decrease from 636 to
612.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
hours
Type of respondent
Form name
State Tobacco Control Program .......
Management Information System ....
51
2
6
612
Total ...........................................
...........................................................
........................
........................
........................
612
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–14788 Filed 6–24–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0773]
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
VerDate Mar<15>2010
18:01 Jun 24, 2014
Jkt 232001
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Surveillance for Severe
Adverse Events Associated with
Treatment of Latent Tuberculosis
Infection (OMB No. 0920–0773, expires
11/30/2014)—Extension—Division of
Tuberculosis Elimination (DTBE),
National Center for HIV, Viral Hepatitis,
STD, and TB Prevention NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
As part of the national tuberculosis
(TB) elimination strategy, the American
Thoracic Society and CDC have
published recommendations for targeted
testing for TB and treatment for latent
TB infection (LTBI) (Morbidity and
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Mortality Weekly Report (MMWR)
2000;49[RR06];1–54). However, between
October 2000 and September 2004, the
CDC received reports of 50 patients with
severe adverse events (SAEs) associated
with the use of the two or three-month
regimen of rifampin and pyrazinamide
(RZ) for the treatment of LTBI; 12 (24%)
patients died (MMWR 2003;52[31]:735–
9).
In 2004, CDC began collecting reports
of SAEs associated with any treatment
regimen for LTBI. For surveillance
purposes, an SAE was defined as any
drug-associated reaction resulting in a
patient’s hospitalization or death after at
least one treatment dose for LTBI.
During 2004–2008, CDC received 17
reports of SAEs in 15 adults and two
children; all patients had received
isoniazid (INH) and had experienced
severe liver injury MMWR 2010;
59:224–9).
Reports of SAEs related to RZ and
INH have prompted a need for this
project (a national surveillance system
of such events). The objective of the
project is to determine the annual
number and temporal trends of SAEs
associated with any treatment for LTBI
in the United States. Surveillance of
such events will provide data to support
periodic evaluation or potential revision
of guidelines for treatment of persons
with LTBI.
On December 9, 2011, CDC published
the Recommendations for Use of an
Isoniazid-Rifapentine Regimen with
Direct Observation to Treat Latent
Mycobacterium tuberculosis Infection in
MMWR 2011;60(48);1650–1653.
Isoniazid-Rifapentin (3HP) is a new
biweekly 3-month treatment regimen for
LTBI. Since 2011, there have been 28
reports of SAE; 26 of these were
associated with 3HP.
The CDC requests approval for a 3year extension of the previously
approved National Surveillance for
Severe Adverse Events Associated with
E:\FR\FM\25JNN1.SGM
25JNN1
]]>Agencies
[Federal Register Volume 79, Number 122 (Wednesday, June 25, 2014)]
[Notices]
[Pages 36065-36066]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-14-0870]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below proposed project or to obtain a copy of the information
collection plan and instruments, call 404-639-7570 or send comments to
Leroy Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send
an email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
Monitoring and Reporting System for Chronic Disease Prevention and
Control Programs (OMB No. 0920-0870, exp. 11/30/2014)--Revision--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Tobacco use is the single most preventable cause of death and
disease in the United States. Tobacco use causes heart disease and
strokes, lung cancer and many other types of cancer, chronic
obstructive pulmonary disease, lung disorders, pregnancy problems,
sudden infant death syndrome, gum disease, and vision problems.
Approximately 480,000 Americans die from tobacco-related illnesses
annually, a higher number of deaths than the combined total deaths from
HIV/AIDS, alcohol use, cocaine use, heroin use, homicides, suicides,
motor vehicle crashes, and fires. For every person who dies from
tobacco use, 20 more people suffer with at least one serious tobacco-
related illness. There are also severe economic consequences of tobacco
use as the U.S. spends approximately $280 billion annually in direct
medical expenses and lost productivity attributable to the effects of
tobacco use.
The National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP) provides funding to health departments in States,
territories, and the District of Columbia to implement and evaluate
chronic disease prevention and control programs, including tobacco
control programs. Currently, CDC has cooperative agreements to support
tobacco control programs in all 50 states and the District of Columbia
under FOA DP14-1415, an extension of FOA DP09-901. These cooperative
agreements technically ended on March 28, 2014, however a one-year cost
extension (DP14-1415) was granted. Due to the cost extension, final
reports on awardee activities are due to CDC approximately 90 days
after the end of the funding period (June 26, 2015).
In order to maintain continuity in progress reporting through the
end of the cost extension, CDC requests OMB approval to continue the
collection of information from tobacco control program awardees for one
year. Awardees will continue to submit semi-annual progress reports
through a Web-based management information system (MIS).
CDC will continue to collect information about each awardee's
tobacco control objectives, planning, activities, resources,
partnerships, strategies, and progress toward meeting objectives.
Awardees will use the information reported through the electronic MIS
to manage and coordinate their activities and to improve their efforts.
CDC will use the information reported through the MIS to document and
monitor each awardee's progress and to make adjustments, as needed, in
the type and level of technical assistance provided to them. The
information collection allows CDC to oversee the use of federal funds,
and identify and disseminate information about successful tobacco
control strategies implemented by awardees. CDC also uses the
information to respond to Congressional and stakeholder inquiries about
awardee
[[Page 36066]]
activities, program implementation, and program impact.
Progress reporting through the MIS is required for CDC funded
awardees. There are no costs to respondents other than their time.
There are no changes to the content of the information collection, the
frequency of information collection, or the estimated burden per
response. The only change is a decrease in the number of tobacco
control program respondents from 53 to 51. Puerto Rico and the Virgin
Islands were originally funded under DP09-901 but discontinued their
participation under the DP14-1415 cost extension. As a result, the
total estimated annualized burden hours will decrease from 636 to 612.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
State Tobacco Control Program. Management 51 2 6 612
Information
System.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 612
----------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-14788 Filed 6-24-14; 8:45 am]
BILLING CODE 4163-18-P
